ES543401A0 - Un procedimiento para la preparacion de una composicion farmaceutica en polvo a base de silice o un silicato poroso. - Google Patents

Un procedimiento para la preparacion de una composicion farmaceutica en polvo a base de silice o un silicato poroso.

Info

Publication number
ES543401A0
ES543401A0 ES543401A ES543401A ES543401A0 ES 543401 A0 ES543401 A0 ES 543401A0 ES 543401 A ES543401 A ES 543401A ES 543401 A ES543401 A ES 543401A ES 543401 A0 ES543401 A0 ES 543401A0
Authority
ES
Spain
Prior art keywords
silicon
procedure
preparation
pharmaceutical composition
powder based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES543401A
Other languages
English (en)
Other versions
ES8800039A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10561403&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES543401(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES8800039A1 publication Critical patent/ES8800039A1/es
Publication of ES543401A0 publication Critical patent/ES543401A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES543401A 1984-05-23 1985-05-22 Un procedimiento para la preparacion de una composicion farmaceutica en polvo a base de silice o un silicato poroso. Expired ES8800039A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848413191A GB8413191D0 (en) 1984-05-23 1984-05-23 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
ES8800039A1 ES8800039A1 (es) 1987-11-01
ES543401A0 true ES543401A0 (es) 1987-11-01

Family

ID=10561403

Family Applications (1)

Application Number Title Priority Date Filing Date
ES543401A Expired ES8800039A1 (es) 1984-05-23 1985-05-22 Un procedimiento para la preparacion de una composicion farmaceutica en polvo a base de silice o un silicato poroso.

Country Status (12)

Country Link
US (2) US4719228A (es)
EP (1) EP0163178B1 (es)
JP (1) JPH0772128B2 (es)
CA (1) CA1255222A (es)
DE (1) DE3580304D1 (es)
ES (1) ES8800039A1 (es)
GB (1) GB8413191D0 (es)
GR (1) GR851254B (es)
IE (1) IE57732B1 (es)
MX (1) MX163564B (es)
NZ (1) NZ212148A (es)
ZA (1) ZA853823B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248700A (en) * 1982-05-14 1993-09-28 Akzo Nv Active agent containing solid structures for prolonged release of active agents
JPS6245537A (ja) * 1985-08-23 1987-02-27 Sumitomo Electric Ind Ltd 医用樹脂組成物及びその製造方法
JPH0621072B2 (ja) * 1986-11-12 1994-03-23 呉羽化学工業株式会社 エストラジオ−ル誘導体よりなる免疫調節剤
US4837255A (en) * 1987-03-10 1989-06-06 Ciba-Geigy Corporation Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
IE60458B1 (en) * 1989-10-26 1994-07-13 Elan Corp Plc Enhanced bioavailability adsorbates
US5030446A (en) * 1990-01-24 1991-07-09 Revlon, Inc. Oil- and talc-free cosmetic powder composition
CA2038744C (en) * 1990-03-23 2002-01-08 Yoshitomi Pharmaceutical Industries Ltd. Pharmaceutical composition containing slightly water-soluble drug
EP0530833B1 (en) * 1991-09-05 1996-04-17 TSUMURA & CO. Process to prepare hard gelatine capsules containing chinese herbal extracts
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
DE19506141A1 (de) 1995-02-22 1996-08-29 Hoechst Ag Verwendung von Aerogelen in der Pharmazie, in der Kosmetik und im Pflanzenschutz
US5766668A (en) * 1995-03-27 1998-06-16 Chinook Group, Inc. Method for synthesizing chloride based feed precursor and product resulting therefrom
SE9704400D0 (sv) 1997-11-28 1997-11-28 Astra Ab Porous inorganic particles as carriers for drug substances
DE19825687A1 (de) * 1998-06-09 1999-12-16 Degussa Wirkstoffkonzentrat
US6303167B1 (en) * 1998-11-09 2001-10-16 Archer-Daniels-Midland Company Method of producing vitamin powders
DK1140027T3 (da) * 1998-12-23 2006-02-27 Alza Corp Doseringsformer indeholdende poröse partikler
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
CA2474838C (en) * 2002-02-01 2009-01-06 Pfizer Products Inc. Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
EP1358805A1 (en) * 2002-04-30 2003-11-05 Aventis Animal Nutrition S.A. Animal feed supplement
CA2516096A1 (en) * 2003-02-19 2004-09-02 Lifecycle Pharma A/S Use of a silica or silica derivative as a sorption material
CA2516448A1 (en) * 2003-02-19 2004-09-02 H. Lundbeck A/S Method for preparation of an agglomerate using melt agglomeration
WO2005011635A2 (en) 2003-08-04 2005-02-10 Pfizer Products Inc. Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
EP1680086A2 (en) * 2003-10-10 2006-07-19 LifeCycle Pharma A/S A solid dosage form comprising a fibrate and a statin
US9173847B2 (en) * 2003-10-10 2015-11-03 Veloxis Pharmaceuticals A/S Tablet comprising a fibrate
CA2540984C (en) 2003-10-10 2011-02-08 Lifecycle Pharma A/S A solid dosage form comprising a fibrate
US20050096390A1 (en) * 2003-10-10 2005-05-05 Per Holm Compositions comprising fenofibrate and pravastatin
US20050153976A1 (en) * 2003-12-17 2005-07-14 Schering Corporation Pharmaceutical compositions
AU2006214443C1 (en) * 2005-02-15 2011-11-24 Alkermes Pharma Ireland Limited Aerosol and injectable formulations of nanoparticulate benzodiazepine
SG183059A1 (en) 2007-02-23 2012-08-30 Gilead Sciences Inc Modulators of pharmacokinetic properties of therapeutics
PL2296633T3 (pl) 2008-05-02 2016-03-31 Gilead Sciences Inc Zastosowanie cząsteczek stałych nośników dla udoskonalenia przetwarzalności środka farmaceutycznego
US8535392B2 (en) * 2008-11-25 2013-09-17 Milliken & Company Solid polymeric colorant compositions
EP3745848A1 (en) * 2018-01-29 2020-12-09 Spécialités Pet Food Litter for promoting pet's in-litter elimination

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2879161A (en) * 1956-05-14 1959-03-24 American Cyanamid Co Stable dry powder compositions containing choline chloride and methods of preparing same
NL125920C (es) * 1960-12-28
SE421042B (sv) * 1976-06-29 1981-11-23 Kockums Chem Sett att minska den for en viss biologisk effekt erforderliga mengden biologiskt aktiv substans
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
GB2107706A (en) * 1981-09-25 1983-05-05 Beecham Group Plc Benzopyrans
US4581232A (en) * 1983-07-20 1986-04-08 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates
DE3409063A1 (de) * 1984-03-13 1985-09-19 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von fliessfaehigen cholinchlorid-kieselsaeure-pulvern

Also Published As

Publication number Publication date
IE57732B1 (en) 1993-03-24
GB8413191D0 (en) 1984-06-27
US4719228A (en) 1988-01-12
AU4280085A (en) 1985-11-28
EP0163178A2 (en) 1985-12-04
JPH0772128B2 (ja) 1995-08-02
JPS60258113A (ja) 1985-12-20
ES8800039A1 (es) 1987-11-01
IE851262L (en) 1985-11-23
CA1255222A (en) 1989-06-06
MX163564B (es) 1992-06-01
US4859709A (en) 1989-08-22
ZA853823B (en) 1986-04-30
DE3580304D1 (de) 1990-12-06
AU589561B2 (en) 1989-10-19
EP0163178B1 (en) 1990-10-31
GR851254B (es) 1985-11-25
NZ212148A (en) 1989-01-06
EP0163178A3 (en) 1987-01-14

Similar Documents

Publication Publication Date Title
ES543401A0 (es) Un procedimiento para la preparacion de una composicion farmaceutica en polvo a base de silice o un silicato poroso.
GB2200109B (en) New pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
ES554625A0 (es) Un procedimiento para la preparacion de una composicion de silicona.
IL75400A0 (en) Dialkoxypyridines,processes for the preparation thereof and pharmaceutical compositions containing the same
IL75120A0 (en) New pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them
DE3888766T2 (de) Novolack-beschichtete keramische Partikel.
ZA878953B (en) New pharmacologically active compounds,methods for the preparation thereof and compositions containing the same
DE3867594D1 (de) Zementzusammensetzung.
MX9121A (es) Composicion de frita de vidrio sin plomo y procedimiento para prepararla.
FI873087A0 (fi) Desensiterande dentalkomposition.
IT8721411A0 (it) Composizione farmaceutica idrosolubile contenente n acetilsisteina.
EP0157346A3 (en) Quinolizinone compound, processes for preparation thereof and pharmaceutical composition comprising the same
IL81950A0 (en) 2-azolylmethyl-2-aryl-1,3-dioxolanes and the salts thereof processes for the preparation thereof and pharmaceutical compositions containing them
IT8721410A0 (it) Composizione farmaceutica idrosolubile contenente n acetilcisteina.
ZA879166B (en) Pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them
DE3777930D1 (de) Halbleitende keramische zusammensetzung.
DE3863957D1 (de) Zementzusammensetzungen.
ES556001A0 (es) Un procedimiento para la preparacion de una composicion de silicona.
ES554527A0 (es) Un procedimiento para la preparacion de una composicion de silicona.
DE3775855D1 (de) Keramische halbleiterzusammensetzung.
ES545307A0 (es) Procedimiento para preparar una composicion absorbente a base de arcilla.
DE179649T1 (de) Keramikwerkstoffe.
PT84339A (pt) 1,6-naphthyridine derivatives process for the preparation thereof and pharmaceutical compositions containing them
DK164535C (da) Etopsidpraeparat til oral administrering
GB8719058D0 (en) Ceramic composition

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20070811